Ilika finds alignment as battery sector expectations evolve

Ilika Plc

Ilika’s latest appearance at the Battery Show North America revealed that the company’s position is becoming more relevant as the battery sector moves into a new phase, one defined less by volume and more by differentiation.

In a year where pricing pressure has hammered conventional lithium-ion suppliers, Ilika’s oxide solid-state chemistry stood out not for its visibility but for its timing. The industry is recalibrating. Battery cell costs, especially in China, have dropped sharply. LFP prices alone fell by up to 20% in 2024, setting a bar that Western producers are unlikely to match without compromising margins. For Ilika, that shift makes its long-standing focus on performance and safety a clear strategic advantage. What became obvious at the show was that leading OEMs are no longer looking just for cheaper batteries. They are looking for safer, more compact, longer-lasting solutions, attributes Ilika has prioritised from the start.

The company noted strong interest in its Stereax technology, which targets applications where footprint and safety are critical. That’s no longer a niche conversation. It’s now central to discussions about how to replace incumbent lithium-ion designs without triggering a new set of risks or costs. Meanwhile, the emergence of LMR (lithium manganese rich) cathodes and nickel-light formulations shows that even major cell developers are searching for ways to move beyond legacy materials, and are increasingly open to external innovation to do it.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search